Kwon, Newland named to antibiotic resistance advisory council
Jennie H. Kwon, DO, an associate professor of medicine in infectious diseases, and Jason G. Newland, MD, a professor of pediatrics, both at the School of Medicine, have been selected to serve on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.
Washington University and Deerfield Management launch VeritaScience to drive drug discovery
Washington University in St. Louis and Deerfield Management, a health-care investment firm, announced the launch of VeritaScience, a new private R&D collaboration designed to advance the discovery, clinical development and commercialization of promising therapeutic and diagnostic candidates with potential to benefit human health.
Old research, new readers
Some Source stories from years past continue to attract new readers. Here, we check in with WashU researchers in linguistics, psychology, engineering and other disciplines to learn more about their work and how the research has progressed.
Awardees announced for Needleman innovation, commercialization program
Three WashU researchers developing promising therapeutics for cancer and heart disease are the inaugural awardees of the Needleman Program for Innovation and Commercialization. The next round of project proposals is now open.
Fehniger receives grant for trial of immunotherapy against melanoma
Todd A. Fehniger, MD, PhD, and colleagues Alice Y. Zhou, MD, PhD, Ryan C. Fields, MD, and George Ansstas, MD, all at the School of Medicine, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.
Life span increases in mice when specific brain cells are activated
A new study from the School of Medicine identifies a key feedback loop between the brain and the fat tissue that governs aging in mice. The research suggests that the loop’s gradual deterioration contributes to health problems typical of aging.
Policy interventions helped save lives during pandemic, study finds
States that emphasized non-pharmaceutical interventions, such as distancing and mask wearing, fared better in curbing the spread of COVID-19, shows a forthcoming study from the Brown School.
Why do we sleep? Researchers propose an answer to this age-old question
Sleep helps restore the brain’s operating system to a critical state, according to new findings from biology and physics researchers in Arts & Sciences.
Metabolism-boosting, bile acid-reducing drugs improve gut health
Researchers at the School of Medicine found that metabolism-boosting, bile acid-reducing drugs improved gut health in mice. The findings indicate a new approach that may help malnourished children with stunted growth.
Study reveals clues to how Eastern equine encephalitis virus invades brain cells
Researchers at the School of Medicine have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings lay a foundation for treatments and vaccines for viral infections.
Older Stories